Astellas Pharma Inc. and Propella Therapeutics, Inc. have entered into a merger agreement, marking a significant development in the field of digital wealth management. Through its U.S. subsidiary...
The globalVector Database marketis anticipated to grow at a CAGR of 25.6% during the forecast period (2023-2030). The increasing availability of cloud-based vector database solutions: Cloud-based...
Posted by cathyy on September 05 at 03:37 AM
public
Why need viral vector characterization?
Cell and gene therapies for various rare diseases are currently undergoing clinical trials worldwide. The rapid development in this field has led to an in...
Recombinant Vector Vaccines Marketis expected to grow at a significant CAGR during the forecast period. The global recombinant vector vaccine market is being driven by rapid advances in molecular...
According to research report the report Viral Vector Manufacturing Market is projected to reach USD 12.8 billion by 2028 from USD 5.5 billion in 2023, at a CAGR of 18.2% during the forecast perio...
